Canopy Growth (CGC) Expected to Announce Earnings on Friday

Canopy Growth (NASDAQ:CGC) will likely be posting its Q4 2026 results before the market opens on Friday, May 29th. Analysts expect Canopy Growth to post earnings of ($0.06) per share and revenue of $53.4260 million for the quarter. Individuals may visit the the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Monday, June 15, 2026 at 10:00 AM ET.

Canopy Growth Trading Up 3.9%

Shares of NASDAQ CGC opened at $1.07 on Friday. Canopy Growth has a 1 year low of $0.84 and a 1 year high of $2.38. The stock has a market cap of $432.41 million, a P/E ratio of -0.82 and a beta of 0.78. The firm has a 50-day moving average of $1.06 and a 200 day moving average of $1.14. The company has a debt-to-equity ratio of 0.30, a current ratio of 5.34 and a quick ratio of 4.26.

Institutional Trading of Canopy Growth

A number of institutional investors and hedge funds have recently bought and sold shares of CGC. Millennium Management LLC increased its stake in Canopy Growth by 196.9% during the 3rd quarter. Millennium Management LLC now owns 3,137,696 shares of the company’s stock valued at $4,579,000 after purchasing an additional 2,080,994 shares in the last quarter. Two Sigma Investments LP bought a new stake in Canopy Growth during the 3rd quarter valued at about $1,767,000. Tidal Investments LLC increased its stake in Canopy Growth by 31.5% during the 2nd quarter. Tidal Investments LLC now owns 5,033,793 shares of the company’s stock valued at $6,141,000 after purchasing an additional 1,204,530 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Canopy Growth by 10,308.3% during the 1st quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company’s stock valued at $882,000 after purchasing an additional 960,218 shares in the last quarter. Finally, Barclays PLC increased its stake in Canopy Growth by 5,436.5% during the 4th quarter. Barclays PLC now owns 897,078 shares of the company’s stock valued at $1,023,000 after purchasing an additional 880,875 shares in the last quarter. 3.33% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. ATB Cormark Capital Markets raised shares of Canopy Growth from a “strong sell” rating to a “moderate buy” rating in a research report on Tuesday, March 17th. Alliance Global Partners reissued a “neutral” rating on shares of Canopy Growth in a research report on Saturday, February 7th. Weiss Ratings cut shares of Canopy Growth from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday. Wall Street Zen cut shares of Canopy Growth from a “hold” rating to a “sell” rating in a research report on Sunday, March 29th. Finally, Canaccord Genuity Group started coverage on shares of Canopy Growth in a research report on Friday, March 27th. They set a “buy” rating for the company. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

About Canopy Growth

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.